Hangzhou Go Top Peptide Biotech Co.,Ltd.

Established in 2014, Hangzhou Go Top Peptide Biotech integrates peptide research, pilot scale-up and commercial manufacturing for partners worldwide, with a research center spanning more than 4,000 square meters in Hangzhou and a cGMP-compliant commercial manufacturing facility spanning 33,000 square meters in Shaoxing, Zhejiang. The company's annual manufacturing capacity targets 2,500 kg of tirzepatide, 2,500 kg of semaglutide and 1,000 kg of peptide intermediates.